The global MRI-compatible IV infusion pump systems market is on a dynamic growth path, with projections showing a significant rise from USD 234.8 million in 2022 to USD 580.3 million by 2032. This ...
Pending FDA approval, the upgraded Prometra Implantable Pump System for the targeted delivery of pain medication will feature MRI compatibility, Flowonix CEO Steve Adler told FierceDrugDelivery in an ...
Iradimed picked up an FDA nod for its MRI-compatible intravenous infusion pump system, which enables patients who can’t be disconnected from IV medication to undergo MRI scanning. The company will now ...
The global MRI-Compatible IV Infusion Pump Systems Market is estimated to be valued at USD 322.5 million in 2025 and is projected to reach USD 742.9 million by 2035, registering a compound annual ...
Iradimed Corporation announced that it has received FDA 510(k) clearance for its next-generation MRidium® 3870 IV Infusion Pump System, making it the only supplier of non-magnetic MRI-compatible ...
New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global MRI Compatible IV Infusion Pumps Market 2022-2026" - https ...
Flowonix, maker of the implantable Prometra infusion pump for chronic pain patients, announced that it has raised $40 million in debt and equity financing, led by private equity fund Élevage Capital ...
WINTER SPRINGS, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today ...
Clinicians using programmable, or smart, syringe pumps should take precautions against mishaps that can occur at low infusion rates of high-risk, life-sustaining therapies, such as those at less than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback